Safety of a second homologous Ad26COV2S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa Vaccine

Simple item page
dc.article.end-page1199en
dc.article.start-page1195en
dc.citation.doi10.1016/J.VACCINE.2024.01.066en
dc.contributor.authorAzwidihwi Takalanien
dc.contributor.authorMichelle Robinsonen
dc.contributor.authorP Jonasen
dc.contributor.authorA Bodensteinen
dc.contributor.authorV Samboen
dc.contributor.authorBarry Jacobsonen
dc.contributor.authorIan Sanneen
dc.contributor.authorGlenda Grayen
dc.date.accessioned2026-04-19T14:39:36Z
dc.departmentIDORIen
dc.facultyFACULTY OF HEALTH SCIENCESen
dc.identifier.citationWOSen
dc.identifier.issn0264-410Xen
dc.identifier.urihttps://hdl.handle.net/10539/49073
dc.journal.titleSafety of a second homologous Ad26COV2S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa Vaccineen
dc.journal.volume42en
dc.titleSafety of a second homologous Ad26COV2S vaccine among healthcare workers in the phase 3b implementation Sisonke study in South Africa Vaccineen
dc.typeJournal Articleen

Files

Original bundle

Now showing 1 - 1 of 1
Thumbnail Image
Name:
Journal Article.pdf
Size:
389.78 KB
Format:
Adobe Portable Document Format
Description:
Bitstream uploaded by REST Client
Download

Collections

Academic Wits Research Outputs (All submissions)